TWST
Twist Bioscience Corporation · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +8 | 54.73M | $5.62B | +14 | −6 |
| Q1 2026 | 108 | +15 | 51.20M | $2.43B | +20 | −5 |
| Q4 2025 | 92 | -2 | 51.46M | $1.63B | +1 | −3 |
| Q3 2025 | 18 | 0 | 32.97M | $927.70M | +1 | −2 |
| Q2 2025 | 16 | -3 | 28.73M | $1.06B | — | −3 |
| Q1 2025 | 16 | +1 | 15.75M | $618.44M | +2 | −1 |
| Q4 2024 | 15 | 0 | 15.20M | $706.21M | — | — |
| Q3 2024 | 14 | +1 | 11.38M | $514.14M | +2 | −1 |
| Q2 2024 | 13 | — | 12.61M | $621.59M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.13M | — | $302.06M | 2.7% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.43M | — | $70.36M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.43M | — | $70.36M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 1.34M | — | $66.13M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 1.34M | — | $66.13M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 782.38K | — | $38.56M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 673.06K | — | $33.17M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 579.23K | — | $28.54M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 276.46K | — | $13.62M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 276.46K | — | $13.62M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (pasivo) | 239.53K | — | $11.80M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 79.05K | — | $3.90M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 61.43K | — | $3.03M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 61.43K | — | $3.03M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 61.43K | — | $3.03M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 34.75K | — | $1.71M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 4.07K | — | $200,767 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 279 tenedores, 76.80M acciones, $3.56B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 854 acc. · $120,220
Officer · 669 acc. · $93,035
Officer · 1.60K acc. · $222,227
Officer · 1.97K acc. · $273,265
Officer · 1.36K acc. · $189,130
Officer · 4.05K acc. · $562,661
Officer, Director · 6.64K acc. · $923,259
Officer · 14.21K acc. · $1.84M
Officer · 2.00K acc. · $245,162
Officer · 6.30K acc. · $761,860
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología